Perrin-Sarrado Caroline, Dahboul Fatima, Leroy Pierre, Lartaud Isabelle
EA3452 CITHEFOR 'Drug Targets, Formulation and Preclinical Assessment', Faculté de Pharmacie, Université de Lorraine, Nancy, France.
Fundam Clin Pharmacol. 2018 Apr;32(2):134-140. doi: 10.1111/fcp.12347. Epub 2018 Feb 1.
S-nitrosoglutathione (GSNO), which is involved in the transport and the storage of NO, induces vasorelaxation. It requires gamma-glutamyl transferase (GGT), an enzyme present on the endothelium, to transfer NO into the cell. We evaluated whether aging and hypertension, which induce NO-related dilating dysfunction, are associated with decreased vascular GGT activity and modify the vasorelaxant effect of GSNO. Thoracic aortic rings isolated from male spontaneous hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) aged 20-22 (adult) or 57-60 weeks (mature) were preconstricted with phenylephrine, then submitted to concentration-vasorelaxant response curves (maximal response: E ; pD ) to GSNO and carbachol (the latter to measure NO-related dilating function). GGT activity was measured using chromogenic substrate. Both aging and hypertension lowered E values for carbachol (E -8% in adult SHR, -42% in mature SHR vs. age-matched WKY, p and p < 0.05) demonstrating NO-related dilating dysfunction. Aortic GGT activity also decreased with aging and hypertension (-22% in adult and -75%, reaching 3 nmol/min/g of tissue, in mature SHR vs. 12 in age-matched WKY and 23 in adult WKY, p and p < 0.05). The pD values of GSNO were similar in mature SHR and WKY but higher in adult SHR (p < 0.05). Aging in hypertensive rats decreased NO-related vasorelaxant function and vascular GGT activity, but did not lower the vasorelaxant response to GSNO. This opens perspectives for GSNO-based therapeutics restoring nitric oxide bioavailability and vascular protection in a context of endothelial dysfunction.
参与一氧化氮(NO)转运和储存的S-亚硝基谷胱甘肽(GSNO)可诱导血管舒张。它需要内皮细胞上存在的一种酶——γ-谷氨酰转移酶(GGT)将NO转运到细胞内。我们评估了诱导与NO相关的舒张功能障碍的衰老和高血压是否与血管GGT活性降低有关,以及是否会改变GSNO的血管舒张作用。从20 - 22周龄(成年)或57 - 60周龄(成熟)的雄性自发性高血压大鼠(SHR)和Wistar - Kyoto大鼠(WKY)分离出胸主动脉环,先用去氧肾上腺素预收缩,然后接受GSNO和卡巴胆碱的浓度 - 血管舒张反应曲线(最大反应:E;pD)(后者用于测量与NO相关 的舒张功能)。使用显色底物测量GGT活性。衰老和高血压均降低了卡巴胆碱的E值(成年SHR中E降低8%,成熟SHR中降低42%,与年龄匹配的WKY相比,p和p < 0.05),表明存在与NO相关的舒张功能障碍。主动脉GGT活性也随着衰老和高血压而降低(成年SHR中降低22%,成熟SHR中降低75%,降至3 nmol/min/g组织,而年龄匹配的WKY为12,成年WKY为23,p和p < 0.05)。GSNO的pD值在成熟SHR和WKY中相似,但在成年SHR中更高(p < 0.05)。高血压大鼠的衰老降低了与NO相关的血管舒张功能和血管GGT活性,但并未降低对GSNO的血管舒张反应。这为基于GSNO的疗法在恢复内皮功能障碍情况下的一氧化氮生物利用度和血管保护方面开辟了前景。